Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Ann Tivey, Rohan Shotton, Toby A. Eyre, David Lewis, Louise Stanton, Rebecca Allchin, Harriet Walter, Fiona Miall, Rui Zhao, Anna Santarsieri, Rory McCulloch, Mark Bishton, Amy Beech, Victoria Willimott, Nicole Fowler, Claudia Bedford, Jack Goddard, Sam Protheroe, Angharad Everden, David Tucker, Josh Wright, Vasavi Dukka, Miriam Reeve, Shankara Paneesha, Mahesh Prahladan, Andrew Hodson, Iman Qureshi, Manasvi Koppana, Mary Owen, Kushani Ediriwickrema, Helen Marr, Jamie Wilson, Jonathan Lambert, David Wrench, Claire Burney, Chloe Knott, Georgina Talbot, Adam Gibb, Angela Lord, Barry Jackson, Simon Stern, Taylor Sutton, Amy Webb, Marketa Wilson, Nicky Thomas, Jane Norman, Elizabeth Davies, Lisa Lowry, Jamie Maddox, Neil Phillips, Nicola Crosbie, Marcin Flont, Emma Nga, Andres Virchis, Raisa Guerrero Camacho, Wunna Swe, Arvind Pillai, Clare Rees, James Bailey, Steve Jones, Susan Smith, Faye Sharpley, Catherine Hildyard, Sajir Mohamedbhai, Toby Nicholson, Simon Moule, Anshuman Chaturvedi, Kim Linton

Blood Adv (2024) 8 (5): 1209–1219.

https://doi.org/10.1182/bloodadvances.2023011152

Published: 2024

Includes: Supplemental data

Journal Articles

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Blood Adv (2024) 8 (4): 878–888.

https://doi.org/10.1182/bloodadvances.2023011305

Published: 2024

Includes: Supplemental data